Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1273087 NEW YORK, NY
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$674,786 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
11 quarters on record

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Derivatives in SLS

reported options exposure · as of Jun 30, 2026
CallValue
$2,895,912
CallShares
196,200
PutValue
$13,372,560
PutShares
906,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 468,410 $232,673,299
2 INSM
INSMED Inc
 2,048,005 $218,358,293
3
1,491,404 $197,954,052
4 JAZZ
Jazz Pharmaceuticals plc
 763,880 $184,072,163
5 ONC
BeOne Medicines Ltd.
 543,323 $154,830,755
6 AXSM
Axsome Therapeutics, Inc.
 556,088 $136,113,659
7 BMRN
Biomarin Pharmaceutical Inc
 2,071,816 $118,549,311
8 REGN
Regeneron Pharmaceuticals, Inc.
 165,120 $102,958,924

All Filings in SLS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,895,912 196,200
2026-06-30 $13,372,560 906,000
2026-03-31 $2,647,980 626,000
2026-03-31 $674,786 159,524
2026-03-31 $914,526 216,200
2025-12-31 $5,232,190 1,387,849
2025-09-30 $506,670 314,702
2025-06-30 $2,468,622 1,127,225
2024-09-30 $57,918 46,335
2024-06-30 $179,033 150,448
2023-12-31 $11,913 11,239
2022-12-31 $144,382 61,179
2022-09-30 $50,061 24,783
2021-09-30 $111,394 12,161